SREBF1 and acute myeloid leukemia: The results indicated that upregulation of TMEM88 inhibited the expression levels of SREBP-1c and FASN and upregulated PPAR-α and ACOX-1 in FFA-induced AML-12 cells (Figure 4A, Figure 5A).